ZDLD20

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

ZDLD20 

ZDLD20 是一种 β-咔啉,是一种选择性、具有口服活性的 CDK4/CycD3 抑制剂,IC50 值为 6.51 μM。ZDLD20 表现出有效的抗 HCT116 活性,包括抑制集落形成、抑制侵袭和迁移、诱导细胞凋亡和阻止细胞周期的 G1 期。ZDLD20 表现出有效的抗癌活性。

ZDLD20

ZDLD20 Chemical Structure

CAS No. : 2762279-02-5

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

ZDLD20, a β-carboline, is orally active and selective CDK4/CycD3 inhibitor with an IC50 value of 6.51  μM. ZDLD20 exhibits potent anti-HCT116 activity including inhibition of colony formation, inhibition of invasion and migration, inducing of apoptosis, and arresting of G1 phase in cell cycle. ZDLD20 exhibits potent anticancer activity[1].

IC50 & Target[1]

CDK4/CycD3

6.51  μM (IC50)

分子量

386.45

Formula

C22H22N6O

CAS 号

2762279-02-5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Deping Li, et al. Facile synthesis of C1-substituted β-carbolines as CDK4 inhibitors for the treatment of cancer. Bioorg Chem. 2022 Apr;121:105659.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务